62332-190 : Febuxostat 40 mg Oral Tablet, Coated
NDC: | 62332-190 |
Labeler: | Alembic Pharmaceuticals Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Febuxostat |
Dosage Form: | Oral Tablet, Coated |
Application #: | ANDA205421 |
Rev. Date: |
Appearance:
Markings: | L440 |
Shapes: |
Round |
Colors: |
Green |
Size (mm): | 9 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 62332-190-08: 80 TABLET, COATED IN 1 CARTON (62332‑190‑08)
- 62332-190-10: 100 TABLET, COATED IN 1 CARTON (62332‑190‑10)
- 62332-190-30: 30 TABLET, COATED IN 1 BOTTLE (62332‑190‑30)
- 62332-190-31: 100 TABLET, COATED IN 1 BOTTLE (62332‑190‑31)
- 62332-190-91: 1000 TABLET, COATED IN 1 BOTTLE (62332‑190‑91)
Active Ingredients:
- Febuxostat
Dosage Strength:
- 40 mg
Inactive Ingredients:
- Lactose Monohydrate
- Microcrystalline Cellulose
- Hydroxypropyl Cellulose (90000 Wamw)
- Croscarmellose Sodium
- Silicon Dioxide
- Magnesium Stearate
- Polyvinyl Alcohol, Unspecified
- Talc
- Polyethylene Glycol 3000
- Titanium Dioxide
- D&c Yellow No. 10
- Fd&c Blue No. 1
- Fd&c Blue No. 2 /
Pharmaceutical Classes:
- Xanthine Oxidase Inhibitor [EPC]
- Xanthine Oxidase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 62332-191 Febuxostat 80 mg Oral Tablet, Coated by Alembic Pharmaceuticals Inc.
- 0054-0413 Febuxostat 40 mg Oral Tablet by Hikma Pharmaceuticals USA Inc
- 0054-0414 Febuxostat 80 mg Oral Tablet by Hikma Pharmaceuticals USA Inc
- 0378-3925 Febuxostat 40 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
- 0378-3926 Febuxostat 80 mg Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
- 0527-2244 Febuxostat 40 mg Oral Tablet by Lannett Company, Inc.
- 0527-2248 Febuxostat 80 mg Oral Tablet by Lannett Company, Inc.
- 0904-7395 Febuxostat 40 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 0904-7396 Febuxostat 80 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 0904-7484 Febuxostat 40 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 0904-7485 Febuxostat 80 mg Oral Tablet, Film Coated by Major Pharmaceuticals
- 14445-156 Febuxostat 40 mg Oral Tablet, Film Coated by Indoco Remedies Limited
- 14445-157 Febuxostat 80 mg Oral Tablet, Film Coated by Indoco Remedies Limited
- 16714-059 Febuxostat 40 mg Oral Tablet, Film Coated by Northstar Rxllc
- 16714-060 Febuxostat 80 mg Oral Tablet, Film Coated by Northstar Rxllc
- 27808-206 Febuxostat 40 mg Oral Tablet by Tris Pharma Inc
- 27808-207 Febuxostat 80 mg Oral Tablet by Tris Pharma Inc
- 33342-274 Febuxostat 40 mg Oral Film by Macleods Pharmaceuticals Limited
- 33342-275 Febuxostat 80 mg Oral Film by Macleods Pharmaceuticals Limited
- 43547-295 Febuxostat 40 mg Oral Tablet by Solco Healthcare Us LLC
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 62332-183Next: 62332-191 >
Related Discussions:
uloric febuxostat tabletdia
Iam on uloric (febuxostat. )tablets80 mg ## Hello, Henry! How are you? Uloric is most commonly used to treat high levels... 1 reply
Iam on uloric (febuxostat. )tablets80 mg ## Hello, Henry! How are you? Uloric is most commonly used to treat high levels... 1 reply
Febuxostat for Gout
Has Febuxostat been approved for gout at this time? ## It does not appear that it has been approved for use yet, it was ... 1 reply
Has Febuxostat been approved for gout at this time? ## It does not appear that it has been approved for use yet, it was ... 1 reply
febuxostat
what is it i suffer from acute gout and allupurinol does not work just makes it worse suffered for 20 years...
what is it i suffer from acute gout and allupurinol does not work just makes it worse suffered for 20 years...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.